Betashares Global Healthcare Ccy Hdg ETF
DRUG
- A$8.56
- 0.07
- 0.83%
Betashares Global Healthcare Ccy Hdg ETF DRUG Strategy
The investment objective of the BetaShares Global Healthcare ETF - Currency Hedged is to provide an investment return that aims to track the performance of the Nasdaq Global exAustralia Healthcare Hedged AUD Index (the “Index”), before taking into account fees and expenses. The Index is designed to track the performance of global companies that are in the Healthcare sector (excluding companies listed in Australia).
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
ETFs News & Analysis
etfs
3 things to check before adding another ETF
Portfolio overlap, cost and whether the new potential piece moves you closer to your goals.
etfs
3 different Vanguard ETFs for Aussie share exposure
All 3 ETFs have earned a Bronze Medalist Rating from our analysts.
etfs
Young & Invested: The hidden costs of active ETFs
Why investing in ETFs requires a deep dive into due diligence.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,721.40 | 31.90 | -0.36% |
| CAC 40 | 7,935.08 | 32.85 | -0.41% |
| DAX 40 | 23,137.45 | 43.08 | -0.19% |
| Dow JONES (US) | 46,091.74 | 498.50 | -1.07% |
| FTSE 100 | 9,544.08 | 8.22 | -0.09% |
| HKSE | 25,830.65 | 99.38 | -0.38% |
| NASDAQ | 22,432.85 | 275.23 | -1.21% |
| Nikkei 225 | 48,537.70 | 165.28 | -0.34% |
| NZX 50 Index | 13,326.90 | 15.92 | -0.12% |
| S&P 500 | 6,617.32 | 55.09 | -0.83% |
| S&P/ASX 200 | 8,447.90 | 35.60 | -0.42% |
| SSE Composite Index | 3,946.74 | 6.93 | 0.18% |